<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="sndx-20260430.xsd" xlink:type="simple"/>
    <context id="C_fac7b982-95ab-4c52-a0a7-063e6a9c8c67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001395937</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="C_fac7b982-95ab-4c52-a0a7-063e6a9c8c67"
      id="F_2f9b86c9-8b40-4368-978a-d0b69b4fee50">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="C_fac7b982-95ab-4c52-a0a7-063e6a9c8c67"
      id="F_386b6794-0b2c-4a2d-92ce-d83a52b57b31">0001395937</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="C_fac7b982-95ab-4c52-a0a7-063e6a9c8c67"
      id="F_a49384fa-585f-4e81-8da7-50111eaf1302">DEFA14A</dei:DocumentType>
    <dei:EntityRegistrantName
      contextRef="C_fac7b982-95ab-4c52-a0a7-063e6a9c8c67"
      id="F_9ef7aae3-2eb9-4fd2-bb05-8b2d0113857e">Syndax Pharmaceuticals, Inc.</dei:EntityRegistrantName>
</xbrl>
